FDA Seeks Public Comments Regarding International Classification Of Cannabis

Generic 16 October 2018 | 0 Comments

The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration. The FDA says that the comments “will be considered in preparing a response […]

Tagged in , , ,

Congressional Committee Approves Legislation To Facilitate Clinical Cannabis Research

Generic 13 September 2018 | 0 Comments

Members of the House Judiciary Committee voted today in favor of legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions which limit investigators ability to […]

Tagged in , , ,

FDA Approves Marketing Of Plant-Derived Marijuana Medicine

Generic 25 June 2018 | 0 Comments

Regulators at the US Food and Drug Administration today granted market approval for Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), for the explicit treatment of two rare forms of severe epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. The FDA’s decision was not unexpected, as the proprietary extract formulation — developed by […]

Tagged in , , ,

Legislation Introduced To End The Federal Government’s Marijuana Production Monopoly

Generic 28 April 2018 | 0 Comments

A bipartisan coalition of over two-dozen federal lawmakers, including House Judiciary Chairman Bob Goodlatte (R-VA) and Matt Gaetz (R-FL), are backing newly introduced legislation — The Medical Cannabis Research Act of 2018 — to facilitate federally-approved clinical trials involving cannabis. Passage of this act would end the University of Mississippi’s existing monopoly on the growth […]

Tagged in , , ,

The FDA Wants To Hear From You About Marijuana Scheduling

Generic 11 April 2018 | 0 Comments

…At least that’s how the public comment process works.  This year, the United Nations World Health Organization is due to review the current international classification of marijuana, THC, cannabidiol, and other related compounds and preparations this year. In the lead-up, the WHO is asking member nations submit feedback, of which no nation is more influential than the […]

Tagged in , , ,